Stroke recovery isn't about waiting for healing-it's about actively rebuilding the brain through science-backed rehab. Learn the phases, therapies, and key factors that make real progress possible after brain injury.
MedWatch is the FDA's public safety reporting system for drugs, devices, and cosmetics. Learn how patients and providers can report adverse events, how the FDA uses these reports to protect public health, and why your report matters.
Apixaban and rivaroxaban are safe and effective at standard doses for obese patients, while dabigatran carries higher bleeding risks. Learn which DOACs work best and what to avoid in obesity.
Giardia and pinworms are two of the most common parasitic infections. Learn how they spread, what symptoms to watch for, and how to treat them effectively with proven medications and hygiene practices.
Antibiotic resistance is caused by bacterial mutations and misuse of drugs. Learn how resistance develops, why it's deadly, and what you can do to help stop it before we enter a post-antibiotic era.
Choosing the right insulin for diabetes depends on your lifestyle, type of diabetes, and cost. Learn how rapid-acting, long-acting, and premixed insulins work, what regimens fit your life, and how to navigate cost and access barriers in 2025.
GLP-1 agonists like Ozempic and Wegovy can increase gallbladder disease risk, especially with rapid weight loss. Learn the abdominal pain red flags - right upper quadrant pain, shoulder radiation, fatty-food triggers - and what to do if you experience them.
Vaping is not harmless. Evidence shows it causes lung inflammation, weakens immune defenses, increases COPD risk, and can lead to severe injuries like EVALI. Even if you've never smoked, vaping puts your lungs at risk.
Manage diabetic neuropathy pain with proven medications and daily foot care. Learn which drugs work best, what to avoid, and how to prevent foot ulcers and amputations.
Learn the latest psoriasis treatment options for plaque, guttate, and systemic forms in 2025. Discover how biologics, oral drugs, and targeted therapies are changing outcomes - with real data on efficacy, cost, and patient experiences.
